Virtu KCG Holdings
AXDX icon

Virtu KCG Holdings’s Accelerate Diagnostics AXDX Stock Holding History

Virtu KCG Holdings’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,411
Closed -$347K – 3054
2016
Q2 		$347K Buy
2,411
+1,334
+124% +$179K 0.01% 1734
2016
Q1 		$155K Buy
+1,077
New +$152K ﹤0.01% 2194

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
JP Morgan Private Wealth Advisors
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
ArrowMark Colorado Holdings
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Virtu KCG Holdings's AXDX Position: Q3 2016 in Review

Virtu KCG Holdings sold out of Accelerate Diagnostics (AXDX) in Q3 2016, closing a stake of 2,411 shares — an estimated $347K sold.

Virtu KCG Holdings first reported a position in AXDX in Q1 2016 and held it in 2 quarters. The position peaked at $347K in Q2 2016. 103 funds tracked by Wall St. Rank hold AXDX as of Q3 2016.

  • Virtu KCG Holdings reported no remaining Accelerate Diagnostics position as of Q3 2016 after selling out during the quarter.
  • Virtu KCG Holdings sold 2,411 Accelerate Diagnostics shares in Q3 2016, an estimated $347K.
  • Virtu KCG Holdings first reported a position in Accelerate Diagnostics in Q1 2016 and held it in 2 quarters.
  • Virtu KCG Holdings's Accelerate Diagnostics position peaked at $347K in Q2 2016.
  • 103 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2016.

Based on Virtu KCG Holdings's 13F filing for Q3 2016, filed 10 Nov 2016.